Curanex Share Price
NASDAQ: CURX | Healthcare$0.00
+0.00 (0.00%) Curanex Stock Performance
Curanex Share Price Chart
$0.00$0.00
L
H
Curanex Quarterly Profit & Loss
All figures in USD
Curanex Annual Profit & Loss
All figures in USD
Curanex Balance Sheet
All figures in USD Million
Curanex Cash Flow
Annually
Corporate Actions
About Curanex
Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout. Phyto-N, is a proprietary botanical extract with chemical components and pharmacological activities that harnesses potential anti-inflammatory properties of a medicinal plant.
Curanex Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $5.76 | $4.34 | -18.95% |
Oct 2026 | $4.72 | $5.36 | +16.67% |
Sep 2026 | $4.70 | $4.59 | +2,025.00% |
Aug 2026 | $0.22 | $0.22 | +5.37% |
Jul 2026 | $0.27 | $0.20 | -25.45% |
Jun 2026 | $0.33 | $0.28 | -16.92% |
May 2026 | $0.40 | $0.33 | -20.81% |
Apr 2026 | $0.52 | $0.42 | -13.46% |
Mar 2026 | $0.43 | $0.48 | +7.33% |
Feb 2026 | $0.35 | $0.45 | +38.89% |
Jan 2026 | $0.37 | $0.32 | -2.70% |
Dec 2025 | $0.46 | $0.33 | -32.04% |